Hepatitis C and HIV prevalence using oral mucosal transudate, and reported drug use and sexual behaviours of youth in custody in British Columbia

Canadian Journal of Public Health

Volumn 100, Issue 2, 2009, Pages 121-124

  Buxton, J A ^a,b   Rothon, D ^c   Durigon, M ^a,b   Lem, M ^d   Tu, A W ^b   Remple, V P ^a   Cook, D ^b   Krajden, M ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

^c British Columbia Ministry of Children and Family Development   (Canada)

^d HEALTH CANADA   (Canada)

Author keywords

Hepatitis C; HIV; Youth

Indexed keywords

HEPATITIS C ANTIBODY; VIRUS ANTIBODY;

ADOLESCENT; AGE; BLOOD; CANADA; FEMALE; HARM REDUCTION; HEALTH SURVEY; HEPATITIS C; HIGH RISK BEHAVIOR; HIV SEROPOSITIVITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; MALE; MOUTH MUCOSA; PRISONER; PROSTITUTION; RISK; RISK FACTOR; SALIVA; SENSITIVITY AND SPECIFICITY; SEXUAL BEHAVIOR; STATISTICS AND NUMERICAL DATA; SUBSTANCE-RELATED DISORDERS; VIROLOGY; YOUNG ADULT;

ADOLESCENT; AGE FACTORS; ANTIBODIES, VIRAL; BRITISH COLUMBIA; FEMALE; HARM REDUCTION; HEALTH SURVEYS; HEPATITIS C; HEPATITIS C ANTIBODIES; HIV SEROPOSITIVITY; HIV-1; HUMANS; MALE; MOUTH MUCOSA; ODDS RATIO; PRISONERS; PROSTITUTION; RISK FACTORS; RISK-TAKING; SALIVA; SENSITIVITY AND SPECIFICITY; SEXUAL BEHAVIOR; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 64949196034     PISSN: 00084263     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03405520     Document Type: Article

References (11)

1. Murphy A, Chittenden M, The McCreary Centre Society. Time Out II: A profile of BC Youth in Custody. Vancouver, BC: The McCreary Centre Society, 2005.
2. Rothon DA, Strathdee SA, Cook D, Cornelisse PG. Determinants of HIVrelated high risk behaviours among young offenders: A window of opportunity. Can J Public Health 1997;88(1):14-17.
3. Calzavara L, Ramuscak N, Burchell AN, Swantee C, Myers T, Ford P, et al. Prevalence of HIV and hepatitis C virus infections among inmates of Ontario remand facilities. CMAJ 2007;177(3):257-61.
4. British Columbia Centre for Disease Control. Annual Summary of Reportable Diseases, 2006. Available online at: www.bccdc.org (Accessed February 9, 2008).
5. Judd A, ParryJ, Hickman M, McDonald T, Jordan L, Lewis K, et al. Evaluation of a modified commercial assay in detecting antibody to hepatitis C virus in oral fluids and dried blood spots. J Med Virol 2003;71(l):49-55.
6. Lewis JG. Steroid analysis in saliva: An overview. Clinical Biochemist Reviews 2006;27:139-46.
7. Miller CL, Strathdee SA, Kerr T, Li K, Wood E. Factors associated with early adolescent initiation into injection drug use: Implications for intervention programs. J Adolesc Health 2006;38:462-64.
8. Frajzyngier V, Neaigus A, Gyarmarthy VA, Miller M, Friedman SR. Gender differences in injection risk behaviors at the first injection episode. Drug Alcohol Depend 2007;89(2-3): 145-52.
9. Miller CL, Johnston C, Spittal PM, Li K, LaLiberte N, Montaner JSG, Schechter MT. Opportunities for prevention: Hepatitis C prevalence and incidence in a cohort of young injection drug users. Hepatol 2002;36:737-42.
10. Fischer B, Powis J, Firestone Cruz M, Rudzinski K, Rehm J. Hepatitis C virus transmission among oral crack users: Viral detection on crack paraphernalia. Eur J Gastroenterol Hepatol 2008;20(l):29-32.
11. Kingsley C, Mark M. Sacred Lives: Aboriginal Children and Youth Speak Out About Sexual Exploitation. Vancouver, BC: Save The Children Canada, 2000.